ArticleClinical pharmacology and therapeutics2017

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.

D M Longo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.